Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year
On July 27, 2012, the Company's stockholders approved an amendment to the Haemonetics Corporation By-laws which increased the maximum size of the Board of Directors from nine to twelve directors. The restated By-laws are attached as an exhibit to this 8-K.

Item 5.07 Submission of Matters to a Vote of Security Holders

Haemonetics Corporation's Annual Meeting of Stockholders was held on July 27, 2012. At the Meeting:
1) The amendment to Haemonetics Corporation's By-laws to allow a maximum of 12 members of the Board of Directors was approved;
2) Paul Black, Ronald Gelbman, Richard Meelia and Ellen Zane were elected to serve as directors of Haemonetics Corporation;
3) Advisory vote regarding the compensation of our named executive officers was approved;
4) The selection of Ernst & Young LLP to serve as the independent registered public accounting firm of Haemonetics Corporation for fiscal year 2013 was ratified.

---

Below are the number of votes cast for or against, the number of abstentions, and the number of broker non-votes:

Amendment to By-laws:
Votes For Votes Against Abstain Broker Non-Vote 24,030,998 86,114 2,774 2,310

Election of Directors:
Director Votes For Withheld Broker Non-Votes Paul Black 23,128,464 149,158 844,574 Ronald Gelbman 22,957,800 319,822 844,574 Richard Meelia 23,134,005 143,617 844,574 Ellen Zane 23,079,184 198,438 844,574

Executive Compensation:
Votes For Votes Against Abstain Broker Non-Vote 22,987,246 262,736 27,640 844,574

Ratification of Auditors:
Votes For Votes Against Abstain Broker Non-Vote 23,954,133 166,374 1,689

---